ABOUT US

Every day more patients entrust us with the care of their and their families’ health. This is why, at HM Hospitales, we firmly believe in publishing our healthcare results as an exercise in total transparency with patients, professionals, collaborators and administrations. 

The demand for our services registers significant increases year after year, thus reflecting the patients’ trust in the quality and efficiency of the HM Hospitales Group. It also provides its users with the so-called Diagnosis-Related Groups (DRGs), with different types of results through efficiency, effectiveness and patient safety indicators that can be freely consulted by hospital. Indicators that are exactly the same as those offered by public and some private bodies and that can be obtained firsthand. These high activity levels enable us to increase our complexity and ensure that our professionals receive the best possible training, with the aim of assuring patients that they are in the best hands. This critical mass of patients and activity also allows us to develop and foster teaching and research with full guarantees. 

We have a Strategic Sustainability Program in place for all HM Hospitales, with the aim of investing in the future, contributing to generating prosperity and minimizing our environmental impact on our surroundings.
Aligned with the 2030 Agenda, our strategy impacts and focuses on the 17 Sustainable Development Goals (SDGs).
With regard to the environment, we work towards ensuring that our hospitals are an added value for our surroundings. 

Our healthcare project is based on sustained growth supported by continuous reinvestment aimed at increasing in size and complexity.
Our centers in Madrid, Toledo, A Coruña, Santiago de Compostela, León, Salamanca, Barcelona and Málaga provide the Group a genuine national character, making HM Hospitales a benchmark of healthcare, technology and research in the Spanish health system. 

Among the main pillars sustaining HM Hospitales is the unequivocal commitment to translational research, which is geared towards bringing new scientific and technological advances in clinical practice closer to the patient. It is a strategic area of the Group that provides our patients with access to new therapies and treatments through clinical trials of drugs and technologies that are not yet on the market.

HM Hospitales is committed to the new digital environment as a transformative axis that enables new forms of relationship between the hospital and patient. From prevention and diagnosis to treatment and monitoring. At HM Hospitales, we work towards optimizing every process, focusing our business model on meeting the needs of our patients and their families 24/7, wherever they are, whatever they need. Our main objective is to improve efficiency and transparency in our relationship with the patient. 

We believe that bringing the latest technological advances to our patients is directly linked to providing them with the best possible healthcare. Therefore, at HM Hospitales we offer diagnostic solutions, disruptive approaches and the incorporation of artificial intelligence, health data and new technologies into all areas of our activity, where possible. Liquid biopsy, molecular diagnostics, technological validation platforms and investment in the incorporation of robotic surgery are examples of this unequivocal commitment to our patients’ and their families’ healthcare. 

At HM Hospitales we are aware that each and every one of the professionals who work here is devoted to patient care.
Therefore, we implement continuous improvement processes that enable us to guarantee the patient and the professional the greatest safety and fully personalized assistance, combining quality care and excellent service.